Evidence map›Paper›PMID 18708146›Full record

ArticleMolecular and cellular neurosciences2008

Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus.

Elisa Matas-Rico, Beatriz García-Diaz, Pedro Llebrez-Zayas, Diana López-Barroso, Luis Santín, Carmen Pedraza, Anibal Smith-Fernández, Pedro Fernández-Llebrez, Teresa Tellez, Maximino Redondo and 3 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Foods (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Lysophospholipid receptors in neurodegeneration and neuroprotection.Exploration of neuroprotective therapy · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Gintonin, aJournal of ginseng research · 2023
    Article
  12. Article
  13. Sex-specific lipid dysregulation in theBrain communications · 2022
    Article
  14. Revisiting the role of lysophosphatidic acid in stem cell biology.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  15. GABAergic deficits in absence of LPABrain structure & function · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Elisa Matas-RicoUnidad de Investigación, Fundación IMABIS, Hospital Regional Universitario Carlos Haya, Málaga, Spain.
Beatriz García-Diaz
Pedro Llebrez-Zayas
Diana López-Barroso
Luis Santín
Carmen Pedraza
Anibal Smith-Fernández
Pedro Fernández-Llebrez
Teresa Tellez
Maximino Redondo
Jerold Chun
Fernando Rodríguez De Fonseca
Guillermo Estivill-Torrús
Universidad de Málaga · ESHospital Regional Universitario de Málaga · ESHospital Costa del Sol · ESScripps Research Institute · US

Funding

RECEPTOR-MEDIATED LPA SIGNALING IN CORTICAL DEVELOPMENTR01MH051699 · NIMH · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI CHUN, JEROLD · 2001 to 2009
$3.3M
Lysophospholipids roles for Schwann cell &myelinationR01NS048478 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI CHUN, JEROLD · 2004 to 2008
$2.4M
CELL LINES FOR FINDING DEVELOPMENTAL NEOCORTICAL GENESR29MH051699 · NIMH · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI CHUN, JEROLD · 1994 to 1998
–
NIMH NIH HHS MH51699NIMH NIH HHS R01 MH051699NINDS NIH HHS NS048478NINDS NIH HHS R01 NS048478
6 · The paper itself

Abstract

Neurogenesis persists in certain regions of the adult brain including the subgranular zone of the hippocampal dentate gyrus wherein its regulation is essential, particularly in relation to learning, stress and modulation of mood. Lysophosphatidic acid (LPA) is an extracellular signaling phospholipid with important neural regulatory properties mediated by specific G protein-coupled receptors, LPA(1-5). LPA(1) is highly expressed in the developing neurogenic ventricular zone wherein it is required for normal embryonic neurogenesis, and, by extension may play a role in adult neurogenesis as well. By means of the analyses of a variant of the original LPA(1)-null mutant mouse, termed the Malaga variant or "maLPA(1)-null," which has recently been reported to have defective neurogenesis within the embryonic cerebral cortex, we report here a role for LPA(1) in adult hippocampal neurogenesis. Proliferation, differentiation and survival of newly formed neurons are defective in the absence of LPA(1) under normal conditions and following exposure to enriched environment and voluntary exercise. Furthermore, analysis of trophic factors in maLPA(1)-null mice demonstrated alterations in brain-derived neurotrophic factor and insulin growth factor 1 levels after enrichment and exercise. Morphological analyses of doublecortin positive cells revealed the anomalous prevalence of bipolar cells in the subgranular zone, supporting the operation of LPA(1) signaling pathways in normal proliferation, maturation and differentiation of neuronal precursors.

Indexed as

Gene DeletionReceptors, Lysophosphatidic AcidAnimalsApoptosisBehavior, AnimalBiomarkersDentate GyrusMiceMice, Inbred C57BLMice, KnockoutNeurogenesisNeuronal PlasticityNeuronsRandom AllocationBiomarkersReceptors, Lysophosphatidic Acid

Identifiers

PMID18708146
PMCPMC3667670
OpenAlexW2032933011

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.